Global Gastrointestinal Stromal Tumor (GIST) Drug Market By Product Type (Amcasertib, Anagrelide hydrochloride CR) And By End-Users/Application (Clinic, Hospital) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-985555
  • April 2021
  • Pharmaceuticals
  • 139 Pages

Report Preview

The Gastrointestinal Stromal Tumor (GIST) Drug market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Gastrointestinal Stromal Tumor (GIST) Drug market research report recommends a business strategy for present market participants to strengthen their position in the market.

According to the report, the Gastrointestinal Stromal Tumor (GIST) Drug market size was USD xx million and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2020-2028. While considering the volume shipments the global Gastrointestinal Stromal Tumor (GIST) Drug market stood at xx (Units/Tons) in 2020 and expected to cross near about xx (units/Tons) by the end of forecast period.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Gastrointestinal Stromal Tumor (GIST) Drug market along with their effects over the forecast period. Similarly, according to the region Gastrointestinal Stromal Tumor (GIST) Drug market research report includes the study of opportunities available in the market situation.

The Gastrointestinal Stromal Tumor (GIST) Drug market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type Amcasertib, Anagrelide hydrochloride CR, APG-1351, Binimetinib, Others
Applications Clinic, Hospital, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Ariad Pharmaceuticals, Inc., Arog Pharmaceuticals, Inc., Array BioPharma Inc., Astex Pharmaceuticals, Inc., Blueprint Medicines Corporation, Boston Biomedical, Inc., Calithera Biosciences, Inc., Chipscreen Biosciences Ltd, Deciphera Pharmaceuticals, LLC, F. Hoffmann-La Roche Ltd., Horizon Pharma Plc, Immunicum AB, Jiangsu Hengrui Medicine Co., Ltd., Kolltan Pharmaceuticals, Inc., Natco Pharma Limited, Nerviano Medical Sciences S.r.l., Novartis AG, Omeros Corporation

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Segmentation by Regions:
In regional analysis, Gastrointestinal Stromal Tumor (GIST) Drug market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Gastrointestinal Stromal Tumor (GIST) Drug market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Gastrointestinal Stromal Tumor (GIST) Drug Market: Value and Forecast
  • U.S.
  • Canada
 
Europe Region for Gastrointestinal Stromal Tumor (GIST) Drug Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 
Asia Pacific Region for Gastrointestinal Stromal Tumor (GIST) Drug Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 
Latin America Region for Gastrointestinal Stromal Tumor (GIST) Drug Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 
Middle East and Africa for Gastrointestinal Stromal Tumor (GIST) Drug Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Global Gastrointestinal Stromal Tumor (GIST) Drug Market Segmentation by Type:
On the basis of product type, global Gastrointestinal Stromal Tumor (GIST) Drug market research report provides the production, revenue, price, and market share and growth rate of each type, primarily split into: Amcasertib, Anagrelide hydrochloride CR, APG-1351, Binimetinib, Others

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Segmentation by Applications:
On the basis of the end users/applications, Gastrointestinal Stromal Tumor (GIST) Drug research report analyze the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Clinic, Hospital, Others

Major Key Players for Global Gastrointestinal Stromal Tumor (GIST) Drug Market:
The Gastrointestinal Stromal Tumor (GIST) Drug market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Ariad Pharmaceuticals, Inc., Arog Pharmaceuticals, Inc., Array BioPharma Inc., Astex Pharmaceuticals, Inc., Blueprint Medicines Corporation, Boston Biomedical, Inc., Calithera Biosciences, Inc., Chipscreen Biosciences Ltd, Deciphera Pharmaceuticals, LLC, F. Hoffmann-La Roche Ltd., Horizon Pharma Plc, Immunicum AB, Jiangsu Hengrui Medicine Co., Ltd., Kolltan Pharmaceuticals, Inc., Natco Pharma Limited, Nerviano Medical Sciences S.r.l., Novartis AG, Omeros Corporation

Important Points Covered by Report:
  • To analyze the value of the Gastrointestinal Stromal Tumor (GIST) Drug market, according to the key region.
  • To study the Gastrointestinal Stromal Tumor (GIST) Drug market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Gastrointestinal Stromal Tumor (GIST) Drug market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Gastrointestinal Stromal Tumor (GIST) Drug research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Gastrointestinal Stromal Tumor (GIST) Drug market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Gastrointestinal Stromal Tumor (GIST) Drug market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Gastrointestinal Stromal Tumor (GIST) Drug market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Gastrointestinal Stromal Tumor (GIST) Drug market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Gastrointestinal Stromal Tumor (GIST) Drug market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Ariad Pharmaceuticals, Inc.
  • Arog Pharmaceuticals, Inc.
  • Array BioPharma Inc.
  • Astex Pharmaceuticals, Inc.
  • Blueprint Medicines Corporation
  • Boston Biomedical, Inc.
  • Calithera Biosciences, Inc.
  • Chipscreen Biosciences Ltd
  • Deciphera Pharmaceuticals, LLC
  • F. Hoffmann-La Roche Ltd.
  • Horizon Pharma Plc
  • Immunicum AB
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Kolltan Pharmaceuticals, Inc.
  • Natco Pharma Limited
  • Nerviano Medical Sciences S.r.l.
  • Novartis AG
  • Omeros Corporation
  • Amcasertib
  • Anagrelide hydrochloride CR
  • APG-1351
  • Binimetinib
  • Others
  • Clinic
  • Hospital
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Snapshot
          2.1.1. Global Gastrointestinal Stromal Tumor (GIST) Drug Market By Type,2019
               2.1.1.1.Amcasertib
               2.1.1.2.Anagrelide hydrochloride CR
               2.1.1.3.APG-1351
               2.1.1.4.Binimetinib
               2.1.1.5.Others
          2.1.2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market By Application,2019
               2.1.2.1.Clinic
               2.1.2.2.Hospital
               2.1.2.3.Others
          2.1.3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market By End-use,2019
          2.1.4. Global Gastrointestinal Stromal Tumor (GIST) Drug Market By Geography,2019

3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Type, 2018 – 2028

5. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Application, 2018 – 2028

6. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By End-use, 2018 – 2028

7. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis, 2018 – 2028 
          7.2.1. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis, 2018 – 2028 
          7.3.1.  Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis, 2018 – 2028 
          7.6.1.  MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Gastrointestinal Stromal Tumor (GIST) Drug Providers
        8.4.1 Ariad Pharmaceuticals, Inc.
                8.1.1 Business Description
                8.1.2 Ariad Pharmaceuticals, Inc. Geographic Operations
                8.1.3 Ariad Pharmaceuticals, Inc. Financial Information
                8.1.4 Ariad Pharmaceuticals, Inc. Product Positions/Portfolio
                8.1.5 Ariad Pharmaceuticals, Inc. Key Developments
        8.4.2 Arog Pharmaceuticals, Inc.
                8.2.1 Business Description
                8.2.2 Arog Pharmaceuticals, Inc. Geographic Operations
                8.2.3 Arog Pharmaceuticals, Inc. Financial Information
                8.2.4 Arog Pharmaceuticals, Inc. Product Positions/Portfolio
                8.2.5 Arog Pharmaceuticals, Inc. Key Developments
        8.4.3 Array BioPharma Inc.
                8.3.1 Business Description
                8.3.2 Array BioPharma Inc. Geographic Operations
                8.3.3 Array BioPharma Inc. Financial Information
                8.3.4 Array BioPharma Inc. Product Positions/Portfolio
                8.3.5 Array BioPharma Inc. Key Developments
        8.4.4 Astex Pharmaceuticals, Inc.
                8.4.1 Business Description
                8.4.2 Astex Pharmaceuticals, Inc. Geographic Operations
                8.4.3 Astex Pharmaceuticals, Inc. Financial Information
                8.4.4 Astex Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.5 Astex Pharmaceuticals, Inc. Key Developments
        8.4.5 Blueprint Medicines Corporation
                8.5.1 Business Description
                8.5.2 Blueprint Medicines Corporation Geographic Operations
                8.5.3 Blueprint Medicines Corporation Financial Information
                8.5.4 Blueprint Medicines Corporation Product Positions/Portfolio
                8.5.5 Blueprint Medicines Corporation Key Developments
        8.4.6 Boston Biomedical, Inc.
                8.6.1 Business Description
                8.6.2 Boston Biomedical, Inc. Geographic Operations
                8.6.3 Boston Biomedical, Inc. Financial Information
                8.6.4 Boston Biomedical, Inc. Product Positions/Portfolio
                8.6.5 Boston Biomedical, Inc. Key Developments
        8.4.7 Calithera Biosciences, Inc.
                8.7.1 Business Description
                8.7.2 Calithera Biosciences, Inc. Geographic Operations
                8.7.3 Calithera Biosciences, Inc. Financial Information
                8.7.4 Calithera Biosciences, Inc. Product Positions/Portfolio
                8.7.5 Calithera Biosciences, Inc. Key Developments
        8.4.8 Chipscreen Biosciences Ltd
                8.8.1 Business Description
                8.8.2 Chipscreen Biosciences Ltd Geographic Operations
                8.8.3 Chipscreen Biosciences Ltd Financial Information
                8.8.4 Chipscreen Biosciences Ltd Product Positions/Portfolio
                8.8.5 Chipscreen Biosciences Ltd Key Developments
        8.4.9 Deciphera Pharmaceuticals, LLC
                8.9.1 Business Description
                8.9.2 Deciphera Pharmaceuticals, LLC Geographic Operations
                8.9.3 Deciphera Pharmaceuticals, LLC Financial Information
                8.9.4 Deciphera Pharmaceuticals, LLC Product Positions/Portfolio
                8.9.5 Deciphera Pharmaceuticals, LLC Key Developments
        8.4.10 F. Hoffmann-La Roche Ltd.
                8.10.1 Business Description
                8.10.2 F. Hoffmann-La Roche Ltd. Geographic Operations
                8.10.3 F. Hoffmann-La Roche Ltd. Financial Information
                8.10.4 F. Hoffmann-La Roche Ltd. Product Positions/Portfolio
                8.10.5 F. Hoffmann-La Roche Ltd. Key Developments
        8.4.11 Horizon Pharma Plc
                8.11.1 Business Description
                8.11.2 Horizon Pharma Plc Geographic Operations
                8.11.3 Horizon Pharma Plc Financial Information
                8.11.4 Horizon Pharma Plc Product Positions/Portfolio
                8.11.5 Horizon Pharma Plc Key Developments
        8.4.12 Immunicum AB
                8.12.1 Business Description
                8.12.2 Immunicum AB Geographic Operations
                8.12.3 Immunicum AB Financial Information
                8.12.4 Immunicum AB Product Positions/Portfolio
                8.12.5 Immunicum AB Key Developments
        8.4.13 Jiangsu Hengrui Medicine Co., Ltd.
                8.13.1 Business Description
                8.13.2 Jiangsu Hengrui Medicine Co., Ltd. Geographic Operations
                8.13.3 Jiangsu Hengrui Medicine Co., Ltd. Financial Information
                8.13.4 Jiangsu Hengrui Medicine Co., Ltd. Product Positions/Portfolio
                8.13.5 Jiangsu Hengrui Medicine Co., Ltd. Key Developments
        8.4.14 Kolltan Pharmaceuticals, Inc.
                8.14.1 Business Description
                8.14.2 Kolltan Pharmaceuticals, Inc. Geographic Operations
                8.14.3 Kolltan Pharmaceuticals, Inc. Financial Information
                8.14.4 Kolltan Pharmaceuticals, Inc. Product Positions/Portfolio
                8.14.5 Kolltan Pharmaceuticals, Inc. Key Developments
        8.4.15 Natco Pharma Limited
                8.15.1 Business Description
                8.15.2 Natco Pharma Limited Geographic Operations
                8.15.3 Natco Pharma Limited Financial Information
                8.15.4 Natco Pharma Limited Product Positions/Portfolio
                8.15.5 Natco Pharma Limited Key Developments
        8.4.16 Nerviano Medical Sciences S.r.l.
                8.16.1 Business Description
                8.16.2 Nerviano Medical Sciences S.r.l. Geographic Operations
                8.16.3 Nerviano Medical Sciences S.r.l. Financial Information
                8.16.4 Nerviano Medical Sciences S.r.l. Product Positions/Portfolio
                8.16.5 Nerviano Medical Sciences S.r.l. Key Developments
        8.4.17 Novartis AG
                8.17.1 Business Description
                8.17.2 Novartis AG Geographic Operations
                8.17.3 Novartis AG Financial Information
                8.17.4 Novartis AG Product Positions/Portfolio
                8.17.5 Novartis AG Key Developments
        8.4.18 Omeros Corporation
                8.18.1 Business Description
                8.18.2 Omeros Corporation Geographic Operations
                8.18.3 Omeros Corporation Financial Information
                8.18.4 Omeros Corporation Product Positions/Portfolio
                8.18.5 Omeros Corporation Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Gastrointestinal Stromal Tumor (GIST) Drug Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Gastrointestinal Stromal Tumor (GIST) Drug: Market Segmentation 
FIG. 2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Gastrointestinal Stromal Tumor (GIST) Drug Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Gastrointestinal Stromal Tumor (GIST) Drug Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Gastrointestinal Stromal Tumor (GIST) Drug Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Gastrointestinal Stromal Tumor (GIST) Drug Providers, 2019
FIG. 11 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Gastrointestinal Stromal Tumor (GIST) Drug market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Gastrointestinal Stromal Tumor (GIST) Drug Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Segment1, 2018 – 2028
TABLE  North America Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Segment2, 2018 – 2028
TABLE  North America Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Country, 2018 – 2028
TABLE  Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Segment1, 2018 – 2028
TABLE  Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Segment2, 2018 – 2028
TABLE  Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Country, 2018 – 2028
TABLE  Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Country, 2018 – 2028
TABLE  MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Segment1, 2018 – 2028
TABLE  MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Segment2, 2018 – 2028
TABLE  MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Value, By Country, 2018 – 2028
TABLE  Ariad Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Arog Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Array BioPharma Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Astex Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Blueprint Medicines Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boston Biomedical, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Calithera Biosciences, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Chipscreen Biosciences Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Deciphera Pharmaceuticals, LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Horizon Pharma Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Immunicum AB: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Jiangsu Hengrui Medicine Co., Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Kolltan Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Natco Pharma Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Nerviano Medical Sciences S.r.l.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Omeros Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Gastrointestinal Stromal Tumor (GIST) Drug Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Gastrointestinal Stromal Tumor (GIST) Drug Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Gastrointestinal Stromal Tumor (GIST) Drug Market, By Geography, 2019 (US$ Mn)
FIG.  Global Gastrointestinal Stromal Tumor (GIST) Drug Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Gastrointestinal Stromal Tumor (GIST) Drug Providers, 2016
FIG.  Global Gastrointestinal Stromal Tumor (GIST) Drug Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Amcasertib Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anagrelide hydrochloride CR Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global APG-1351 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Binimetinib Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gastrointestinal Stromal Tumor (GIST) Drug Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Hospital Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Gastrointestinal Stromal Tumor (GIST) Drug Market Value, 2018 – 2028, (US$ Mn)